Immunovant
在场
是其中之一......
Sumitomo Chemical 是一家在股票代码 4005 (JP) 下上市的公司。
Sumitomo Chemical 在 6 个国家有直接业务。Sumitomo Chemical 拥有 27家子公司，其中包括 Asahi Chemical、Covant Therapeutics 和 Datavant。
他们在：
高管
查看带有其 43 名主要高管的组织结构图
Immunovant 搜索最多的简介
- Pete Salzmann, Chief Executive Officer and Director
- George Migausky, Director
- Douglas Hughes, Director
创建提醒
跟踪 Immunovant 的高管变动
生物技术
Sumitomo Chemical 拥有 2,316 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
- Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
- TuHura Biosciences and Kintara Therapeutics have merged (公布2024十月20号)..
生物技术 行业的其他推荐联系人
消息
Immunovant 的最新新闻稿
- Immunovant Announces Oral Presentation of Late Breaking Abstract for Phase 2 Graves’ Disease Clinical Data at the 2024 American Thyroid Association (ATA) Annual Meeting
- Immunovant to Host Graves’ Disease Program Update on September 9, 2024
- Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended June 30, 2024
- Press Releases
- Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024
- Immunovant Awarded U.S. Patent for IMVT-1402
- Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended December 31, 2023
- Immunovant to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Immunovant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
- Immunovant Announces Positive IMVT-1402 Initial 600 mg MAD Results that Confirm Best-in-Class Potential
- View more press releases Close
关于 Immunovant 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Pete Salzmann 
